OSAKA -- Activist investor Oasis Management has called on Kobayashi Pharmaceutical to file a lawsuit against seven people, including current and former executives of the Japanese drugmaker, Nikkei has learned.
Pharmaceuticals
Oasis petitions Kobayashi Pharma to sue executives for $67m
Activist investor wants payment of damages tied to red yeast supplement scandal
Kobayashi Pharma booked extraordinary losses of over 10 billion yen relating to the red yeast supplement scandal between January and September. (Photo by Ryutaro Yokoyama)
Read Next
.jpg?width=700&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=394)
Latest on Pharmaceuticals
